Paricalcitol
- Generic Name
- Paricalcitol
- Brand Names
- Zemplar
- Drug Type
- Small Molecule
- Chemical Formula
- C27H44O3
- CAS Number
- 131918-61-1
- Unique Ingredient Identifier
- 6702D36OG5
- Background
Paricalcitol is a synthetic vitamin D analog. Paricalcitol has been used to reduce parathyroid hormone levels. Paricalcitol is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure.
- Indication
For treatment of secondary hyperparathyroidism associated with chronic kidney disease (CKD) Stage 3 and 4
- Associated Conditions
- Secondary Hyperparathyroidism (SHPT)
- Associated Therapies
- -
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
- Conditions
- First Posted Date
- 2003-12-04
- Last Posted Date
- 2006-08-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 30
- Registration Number
- NCT00073710
- Locations
- 🇺🇸
Creighton University, Omaha, Nebraska, United States
Paricalcitol in Treating Patients With Myelodysplastic Syndrome
- Conditions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2018-01-29
- Lead Sponsor
- Cedars-Sinai Medical Center
- Registration Number
- NCT00064376
- Locations
- 🇺🇸
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
- Conditions
- First Posted Date
- 2002-11-04
- Last Posted Date
- 2006-08-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 68
- Registration Number
- NCT00048451
- Locations
- 🇺🇸
Medisphere Medical Research Center, Evansville, Indiana, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸Biolab Research, LLC, Rockville, Maryland, United States
Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
- Conditions
- First Posted Date
- 2002-11-04
- Last Posted Date
- 2006-08-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 68
- Registration Number
- NCT00048438
- Locations
- 🇺🇸
Nephrology Association of South Miami, Miami, Florida, United States
🇺🇸Dallas Nephrology Associates, Dallas, Texas, United States
🇺🇸Arms, Dodge, Robinson, Wilber and Crouch, Kansas City, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.